Williams, Thomas;
Mishra, Rhea;
Bharkhada, Brina;
Shields, Aoife;
Dorsey, Rachel;
Chataway, Jeremy;
Brownlee, Wallace J;
(2022)
Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2021-328340.
(In press).
Preview |
Text
jnnp-2021-328340.full.pdf - Published Version Download (303kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1136/jnnp-2021-328340 |
| Publisher version: | https://doi.org/10.1136/jnnp-2021-328340 |
| Language: | Vietnamese |
| Additional information: | © Author(s) (or their employer[s]) 2022. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license (http://creativecommons.org/licenses/by-nc/4.0/). |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neuroinflammation UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10145017 |
Archive Staff Only
 |
View Item |
